Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor
作者： Jeffrey N. Joyce , Cheryl Woolsey , Han Ryoo , Sabine Borwege , Diane Hagner
关键词: MPTP 、 Tyrosine hydroxylase 、 Substantia nigra 、 Internal medicine 、 Pharmacology 、 Pramipexole 、 Biology 、 Endocrinology 、 Agonist 、 Dopamine receptor D3 、 Dopamine 、 Dopamine transporter
摘要: … expression of DAT or the functional properties of DAT might … of MPTP requires DAT [4], then when DAT is downregulated … be most pronounced, regulation of DAT may be important. In …
biomedcentral.com
springer.com
paperity.org参考文章(50)
W. D. Rausch, W. Gsell, Klaus W. Lange, M. Naumann, E. Oestreicher, P. Riederer, Neuroprotection by dopamine agonists Journal of Neural Transmission-supplement. ,vol. 43, pp. 183- 201 ,(1994)
D. Muralikrishnan, K. P. Mohanakumar, Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice The FASEB Journal. ,vol. 12, pp. 905- 912 ,(1998) , 10.1096/FASEBJ.12.10.905
Michael D. Slater, Brain Imaging to Assess the Effects of Dopamine Agonists on Progression of Parkinson Disease JAMA. ,vol. 288, pp. 311- 313 ,(2002) , 10.1001/JAMA.288.3.311
A. Zapata, T. S. Shippenberg, D3 receptor ligands modulate extracellular dopamine clearance in the nucleus accumbens Journal of Neurochemistry. ,vol. 81, pp. 1035- 1042 ,(2002) , 10.1046/J.1471-4159.2002.00893.X
M Spedding, L Cistarelli, V Audinot, J Vian, A Gobert, J M Rivet, J L Peglion, M J Millan, Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways. Journal of Pharmacology and Experimental Therapeutics. ,vol. 275, pp. 899- 913 ,(1995)
Timothy E. Koeltzow, Ming Xu, Donald C. Cooper, Xiu-Ti Hu, Susumu Tonegawa, Marina E. Wolf, Francis J. White, Alterations in Dopamine Release But Not Dopamine Autoreceptor Function in Dopamine D3 Receptor Mutant Mice The Journal of Neuroscience. ,vol. 18, pp. 2231- 2238 ,(1998) , 10.1523/JNEUROSCI.18-06-02231.1998
Joyce Ar, Kimmel Hl, Carroll Fi, Kuhar Mj, Dopamine D1 and D2 Receptors Influence Dopamine Transporter Synthesis and Degradation in the Rat Journal of Pharmacology and Experimental Therapeutics. ,vol. 298, pp. 129- 140 ,(2001)
J. Langston, P Ballard, J. Tetrud, I Irwin, Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis Science. ,vol. 219, pp. 979- 980 ,(1983) , 10.1126/SCIENCE.6823561
CE Clarke, M Guttman, Dopamine agonist monotherapy in Parkinson's disease The Lancet. ,vol. 360, pp. 1767- 1769 ,(2002) , 10.1016/S0140-6736(02)11668-0
Andres D. Ramirez, Stephen K.-F. Wong, Frank S. Menniti, Pramipexole inhibits MPTP toxicity in mice by dopamine D3 receptor dependent and independent mechanisms European Journal of Pharmacology. ,vol. 475, pp. 29- 35 ,(2003) , 10.1016/S0014-2999(03)02087-9